Kazia Therapeutics Limited (KZIA)
NASDAQ: KZIA · Real-Time Price · USD
12.39
+0.54 (4.51%)
Apr 29, 2026, 10:28 AM EDT - Market open
Kazia Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 29, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| Market Capitalization | 142 | 7 | 7 | 26 | 58 | 128 | |
| Market Cap Growth | 5343.16% | 2.91% | -74.25% | -54.61% | -54.40% | 298.54% | |
| Enterprise Value | 90 | 5 | 5 | 24 | 47 | 113 | |
| Last Close Price | 11.85 | 6.27 | 11.43 | 58.00 | 210.00 | 493.00 | |
| PS Ratio | 107.82 | 5.85 | 4.11 | 39743.17 | 8458.34 | 11.23 | |
| PB Ratio | 4.33 | -1.29 | -1.02 | 3.30 | 4.63 | 4.50 | |
| P/TBV Ratio | 4.51 | - | - | - | - | 10.76 | |
| EV/Sales Ratio | 71.29 | 4.34 | 2.80 | 35823.57 | 6855.40 | 9.91 | |
| Debt / Equity Ratio | 0.00 | -0.05 | -0.06 | 0.15 | 0.10 | - | |
| Net Debt / Equity Ratio | -1.49 | 0.48 | 0.10 | -0.29 | -0.30 | -0.73 | |
| Net Debt / EBITDA Ratio | 3.89 | 0.30 | 0.04 | 0.16 | 0.24 | 5.40 | |
| Net Debt / FCF Ratio | 4.82 | 0.30 | 0.11 | 0.23 | 0.24 | 3.03 | |
| Asset Turnover | 0.04 | 0.13 | 0.10 | 0 | 0 | 0.37 | |
| Quick Ratio | 2.86 | 0.32 | 0.07 | 0.71 | 1.10 | 3.32 | |
| Current Ratio | 2.87 | 0.35 | 0.24 | 1.42 | 1.40 | 3.53 | |
| Return on Equity (ROE) | -106.90% | - | -2634.33% | -134.97% | -89.14% | -32.41% | |
| Return on Assets (ROA) | -25.70% | -64.28% | -71.63% | -47.18% | -33.76% | -9.83% | |
| Return on Capital Employed (ROCE) | -39.20% | 177.90% | 675.70% | -117.70% | -87.00% | -12.80% | |
| Earnings Yield | -11.14% | -193.64% | -262.32% | -51.49% | -29.57% | -4.94% | |
| FCF Yield | -7.55% | -124.20% | -93.86% | -38.14% | -26.91% | -5.34% | |
| Buyback Yield / Dilution | -213.01% | -107.81% | -43.08% | -39.12% | -12.57% | -61.08% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.